Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Oncology (Williston Park, N.Y.)

Results: 1-25/1333

Authors: Barlas, S
Citation: S. Barlas, Critical report from the institute of medicine, ONCOLOGY-NY, 15(8), 2001, pp. 943-943

Authors: Barlas, S
Citation: S. Barlas, Pain control an issue again, ONCOLOGY-NY, 15(8), 2001, pp. 943-943

Citation: Reducing exposure to environmental tobacco smoke in communities and health-care systems, ONCOLOGY-NY, 15(8), 2001, pp. 959

Authors: Hamilton, A Volm, M
Citation: A. Hamilton et M. Volm, Nonsteroidal and steroidal aromatase inhibitors in breast cancer, ONCOLOGY-NY, 15(8), 2001, pp. 965-972

Authors: Harvey, HA
Citation: Ha. Harvey, Nonsteroidal and steroidal aromatase inhibitors in breast cancer - The Hamilton/Volm article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 972

Authors: Buzdar, AU
Citation: Au. Buzdar, Nonsteroidal and steroidal aromatase inhibitors in breast cancer - The Hamilton/Volm article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 978-979

Citation: Interim results of OvaRex clinical trial demonstrate clinical benefit in ovarian cancer patients, ONCOLOGY-NY, 15(8), 2001, pp. 983-983

Citation: Docetaxel combination shows significant survival advantage as first-line treatment for advanced lung cancer, ONCOLOGY-NY, 15(8), 2001, pp. 983

Citation: Study finds chemoradiation helps preserve larynx in cancer patients, ONCOLOGY-NY, 15(8), 2001, pp. 986-986

Authors: Gilbert, HS
Citation: Hs. Gilbert, Diagnosis and treatment of thrombocythemia in myeloproliferative disorders, ONCOLOGY-NY, 15(8), 2001, pp. 989

Authors: Tefferi, A
Citation: A. Tefferi, Diagnosis and treatment of thrombocythemia in myeloproliferative disorders- The Gilbert article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 999-1000

Authors: Haire, WD
Citation: Wd. Haire, Diagnosis and treatment of thrombocythemia in myeloproliferative disorders- The Gilbert article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1000

Authors: Chen, HX Gore-Langton, RE Cheson, BD
Citation: Hx. Chen et al., Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab, ONCOLOGY-NY, 15(8), 2001, pp. 1017

Authors: Bow, EJ
Citation: Ej. Bow, Invasive aspergillosis in cancer patients, ONCOLOGY-NY, 15(8), 2001, pp. 1035-1039

Authors: Denning, DW
Citation: Dw. Denning, Invasive aspergillosis in cancer patients - The Bow article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1040

Authors: Freifeld, A
Citation: A. Freifeld, Invasive aspergillosis in cancer patients - The Bow article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1043

Authors: D'Amico, AV
Citation: Av. D'Amico, Combined-modality staging for localized adenocarcinoma of the prostate, ONCOLOGY-NY, 15(8), 2001, pp. 1049-1059

Authors: Moul, JW
Citation: Jw. Moul, Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1060-1062

Authors: Ray, ME Sandler, HM
Citation: Me. Ray et Hm. Sandler, Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1064-1065

Authors: Potters, L Kattan, MW Scardino, PT
Citation: L. Potters et al., Combined-modality staging for localized adenocarcinoma of the prostate - The D'Amico article reviewed, ONCOLOGY-NY, 15(8), 2001, pp. 1065

Citation: Environmental links to breast cancer, ONCOLOGY-NY, 15(7), 2001, pp. 813-813

Citation: Bush administration considering physician ratings, ONCOLOGY-NY, 15(7), 2001, pp. 813-813

Citation: Older breast cancer patients benefit from weekly administration of paclitaxel, ONCOLOGY-NY, 15(7), 2001, pp. 830

Citation: Doxorubicin/Paclitaxel combination does not expose breast cancer patients to excessive cardiac risk, ONCOLOGY-NY, 15(7), 2001, pp. 830-830

Citation: Atrasentan prolongs time to progression in prostate cancer patients, ONCOLOGY-NY, 15(7), 2001, pp. 833
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>